Science 10 September 1976: Vol. 193. no. 4257, pp. 1007 - 1008 DOI: 10.1126/science.181845

Prev | Table of Contents | Next

Articles

Cell Cycle Progression following Naive T Cell Activation Is Independent of Jak3/Common {gamma}-Chain Cytokine Signals.

M. Shi, T. H. Lin, K. C. Appell, and L. J. Berg (2009)
J. Immunol. 183, 4493-4501
 |  Abstract »  |  Full Text »  |  PDF »

Left Posterior Fascicular Block Due to High-Dose Interleukin-2.

A. Singla and S. R Denmeade (2008)
Ann. Pharmacother. 42, 1340-1343
 |  Abstract »  |  Full Text »  |  PDF »

IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.

C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo (2008)
Blood 111, 5326-5333
 |  Abstract »  |  Full Text »  |  PDF »

IL-21 promotes T lymphocyte survival by activating the phosphatidylinositol-3 kinase signaling cascade.

V. Ostiguy, E.-L. Allard, M. Marquis, J. Leignadier, and N. Labrecque (2007)
J. Leukoc. Biol. 82, 645-656
 |  Abstract »  |  Full Text »  |  PDF »

IL-2: More Than a T Cell Growth Factor.

J. J. Oppenheim (2007)
J. Immunol. 179, 1413-1414
 |  Full Text »  |  PDF »

Effects of the Administration of High-Dose Interleukin-2 on Immunoregulatory Cell Subsets in Patients with Advanced Melanoma and Renal Cell Cancer.

H. J.J. van derVliet, H. B. Koon, S. C. Yue, B. Uzunparmak, V. Seery, M. A. Gavin, A. Y. Rudensky, M. B. Atkins, S. P. Balk, and M. A. Exley (2007)
Clin. Cancer Res. 13, 2100-2108
 |  Abstract »  |  Full Text »  |  PDF »

IL-2 and IL-18 Attenuation of Airway Hyperresponsiveness Requires STAT4, IFN-{gamma}, and Natural Killer Cells.

S. Matsubara, K. Takeda, T. Kodama, A. Joetham, N. Miyahara, T. Koya, C. H. Swasey, M. Okamoto, A. Dakhama, and E. W. Gelfand (2007)
Am. J. Respir. Cell Mol. Biol. 36, 324-332
 |  Abstract »  |  Full Text »  |  PDF »

CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation.

J. M. Carr, M. J. Carrasco, J. E. D. Thaventhiran, P. J. Bambrough, M. Kraman, A. D. Edwards, A. Al-Shamkhani, and D. T. Fearon (2006)
PNAS 103, 19454-19459
 |  Abstract »  |  Full Text »  |  PDF »

Ligation of CD80 Is Critical for High-Level CD25 Expression on CD8+ T Lymphocytes.

S. Pejawar-Gaddy and M. A. Alexander-Miller (2006)
J. Immunol. 177, 4495-4502
 |  Abstract »  |  Full Text »  |  PDF »

Inhibition of IL-2 Induced IL-10 Production as a Principle of Phase-Specific Immunotherapy.

M. Bodas, N. Jain, A. Awasthi, S. Martin, R. K. Penke Loka, D. Dandekar, D. Mitra, and B. Saha (2006)
J. Immunol. 177, 4636-4643
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo.

P. A. Antony, C. M. Paulos, M. Ahmadzadeh, A. Akpinarli, D. C. Palmer, N. Sato, A. Kaiser, C. Heinrichs, C. A. Klebanoff, Y. Tagaya, et al. (2006)
J. Immunol. 176, 5255-5266
 |  Abstract »  |  Full Text »  |  PDF »

Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.

Y. Tabakin-Fix, I. Azran, Y. Schavinky-Khrapunsky, O. Levy, and M. Aboud (2006)
Carcinogenesis 27, 673-681
 |  Abstract »  |  Full Text »  |  PDF »

IL-2 administration increases CD4+CD25hi Foxp3+ regulatory T cells in cancer patients.

M. Ahmadzadeh and S. A. Rosenberg (2006)
Blood 107, 2409-2414
 |  Abstract »  |  Full Text »  |  PDF »

Crystal structure of the IL-2 signaling complex: Paradigm for a heterotrimeric cytokine receptor.

D. J. Stauber, E. W. Debler, P. A. Horton, K. A. Smith, and I. A. Wilson (2006)
PNAS 103, 2788-2793
 |  Abstract »  |  Full Text »  |  PDF »

IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation.

M. L. Janas, P. Groves, N. Kienzle, and A. Kelso (2005)
J. Immunol. 175, 8003-8010
 |  Abstract »  |  Full Text »  |  PDF »

Synergistic Antitumor Response of Interleukin 2 with Melphalan in Isolated Limb Perfusion in Soft Tissue Sarcoma-Bearing Rats.

S. Hoving, F. Brunstein, G. aan de Wiel-Ambagtsheer, S. T. van Tiel, G. de Boeck, E. A. de Bruijn, A. M.M. Eggermont, and T. L.M. ten Hagen (2005)
Cancer Res. 65, 4300-4308
 |  Abstract »  |  Full Text »  |  PDF »

Contrasting Effects of Low-Dose IL-2 on Vaccine-Boosted Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cells in Macaques Chronically Infected with SIVmac251.

J. Nacsa, Y. Edghill-Smith, W.-P. Tsai, D. Venzon, E. Tryniszewska, A. Hryniewicz, M. Moniuszko, A. Kinter, K. A. Smith, and G. Franchini (2005)
J. Immunol. 174, 1913-1921
 |  Abstract »  |  Full Text »  |  PDF »

History of lectins: from hemagglutinins to biological recognition molecules.

N. Sharon and H. Lis (2004)
Glycobiology 14, 53R-62R
 |  Abstract »  |  Full Text »  |  PDF »

Phosphorylation of Grb2-Associated Binder 2 on Serine 623 by ERK MAPK Regulates Its Association with the Phosphatase SHP-2 and Decreases STAT5 Activation.

M. Arnaud, C. Crouin, C. Deon, D. Loyaux, and J. Bertoglio (2004)
J. Immunol. 173, 3962-3971
 |  Abstract »  |  Full Text »  |  PDF »

Propagation and Control of T Cell Responses by Heparan Sulfate-Bound IL-2.

L. E. Wrenshall, J. L. Platt, E. T. Stevens, T. N. Wight, and J. D. Miller (2003)
J. Immunol. 170, 5470-5474
 |  Abstract »  |  Full Text »  |  PDF »

Identification of a Protein Fragment of Interleukin 2 Responsible for Vasopermeability.

A. L. Epstein, M. M. Mizokami, J. Li, P. Hu, and L. A. Khawli (2003)
J Natl Cancer Inst 95, 741-749
 |  Abstract »  |  Full Text »  |  PDF »

Stochastic Model of T Cell Proliferation: A Calculus Revealing IL-2 Regulation of Precursor Frequencies, Cell Cycle Time, and Survival.

E. K. Deenick, A. V. Gett, and P. D. Hodgkin (2003)
J. Immunol. 170, 4963-4972
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials.

D. Adu, P. Cockwell, N. J Ives, J. Shaw, and K. Wheatley (2003)
BMJ 326, 789
 |  Abstract »  |  Full Text »  |  PDF »

CC Chemokine Ligand 3 (CCL3) Regulates CD8+-T-Cell Effector Function and Migration following Viral Infection.

M. J. Trifilo, C. C. Bergmann, W. A. Kuziel, and T. E. Lane (2003)
J. Virol. 77, 4004-4014
 |  Abstract »  |  Full Text »  |  PDF »

Clinical advances in therapies targeting the interleukin-2 receptor.

A.C. Church (2003)
QJM 96, 91-102
 |  Full Text »  |  PDF »

Rational approaches to human cancer immunotherapy.

I. D. Davis, M. Jefford, P. Parente, and J. Cebon (2003)
J. Leukoc. Biol. 73, 3-29
 |  Abstract »  |  Full Text »  |  PDF »

Systemic Administration of IL-15 Augments the Antigen-Specific Primary CD8+ T Cell Response Following Vaccination with Peptide-Pulsed Dendritic Cells.

M. P. Rubinstein, A. N. Kadima, M. L. Salem, C. L. Nguyen, W. E. Gillanders, and D. J. Cole (2002)
J. Immunol. 169, 4928-4935
 |  Abstract »  |  Full Text »  |  PDF »

Glycoinositol Phospholipid-anchored Interleukin 2 but not Secreted Interleukin 2 Inhibits Melanoma Tumor Growth in Mice.

J. Ji, J. Li, L. M. Holmes, K. E. Burgin, X. Yu, T. E. Wagner, and Y. Wei (2002)
Mol. Cancer Ther. 1, 1019-1024
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-2-collagen chimeric protein which liberates interleukin-2 upon collagenolysis.

M. Hayashi, M. Tomita, and K. Yoshizato (2002)
Protein Eng. Des. Sel. 15, 429-436
 |  Abstract »  |  Full Text »  |  PDF »

Single centre experience with basiliximab in paediatric renal transplantation.

L. Pape, J. Strehlau, T. Henne, K. Latta, B. Nashan, J. H. H. Ehrich, J. Klempnauer, and G. Offner (2002)
Nephrol. Dial. Transplant. 17, 276-280
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-18 (IL-18) Synergizes with IL-2 to Enhance Cytotoxicity, Interferon-{{gamma}} Production, and Expansion of Natural Killer Cells.

Y.-I. Son, R. M. Dallal, R. B. Mailliard, S. Egawa, Z. L. Jonak, and M. T. Lotze (2001)
Cancer Res. 61, 884-888
 |  Abstract »  |  Full Text »

Broad Programming by IL-2 Receptor Signaling for Extended Growth to Multiple Cytokines and Functional Maturation of Antigen-Activated T Cells.

T. R. Malek, A. Yu, P. Scibelli, M. G. Lichtenheld, and E. K. Codias (2001)
J. Immunol. 166, 1675-1683
 |  Abstract »  |  Full Text »  |  PDF »

Advances in interleukin 2 receptor targeted treatment.

J. C Morris and T. A Waldmann (2000)
Ann Rheum Dis 59, i109-114
 |  Abstract »  |  Full Text »  |  PDF »

Rapid Generation of Potent and Tumor-specific Cytotoxic T Lymphocytes by Interleukin 18 Using Dendritic Cells and Natural Killer Cells.

F. Tanaka, W. Hashimoto, H. Okamura, P. D. Robbins, M. T. Lotze, and H. Tahara (2000)
Cancer Res. 60, 4838-4844
 |  Abstract »  |  Full Text »

Interleukin 2 Treatment for HIV Infection.

J. Blankson and R. F. Siliciano (2000)
JAMA 284, 236-238
 |  Full Text »  |  PDF »

Viral Disease in Hematology.

G. Franchini, R. F. Ambinder, and M. Barry (2000)
Hematology 2000, 409-423
 |  Abstract »  |  Full Text »  |  PDF »

Cytokines in asthma.

K F Chung and P J Barnes (1999)
Thorax 54, 825-857
 |  Full Text »

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993.

M. B. Atkins, M. T. Lotze, J. P. Dutcher, R. I. Fisher, G. Weiss, K. Margolin, J. Abrams, M. Sznol, D. Parkinson, M. Hawkins, et al. (1999)
J. Clin. Oncol. 17, 2105
 |  Abstract »  |  Full Text »  |  PDF »

Interleukin-2 Inhibits the Synthesis and Release of Prolactin from Human Decidual Cells.

Y. Kanda, H. Jikihara, E. Markoff, and S. Handwerger (1999)
J. Clin. Endocrinol. Metab. 84, 677-681
 |  Abstract »  |  Full Text »

IL-2 Induces STAT4 Activation in Primary NK Cells and NK Cell Lines, But Not in T Cells.

K. S. Wang, J. Ritz, and D. A. Frank (1999)
J. Immunol. 162, 299-304
 |  Abstract »  |  Full Text »  |  PDF »

Inflammatory Mediators of Asthma: An Update.

P. J. Barnes, K. F. Chung, and C. P. Page (1998)
Pharmacol. Rev. 50, 515-596
 |  Abstract »  |  Full Text »  |  PDF »

Lung Lymphocytes Proliferate Minimally in the Murine Pulmonary Immune Response to Intratracheal Sheep Erythrocytes.

G. D. Seitzman, J. Sonstein, S. Kim, W. Choy, and J. L. Curtis (1998)
Am. J. Respir. Cell Mol. Biol. 18, 800-812
 |  Abstract »  |  Full Text »

Endogenous IL-2 in Cancer Cells: A Marker of Cellular Proliferation.

T. E. Reichert, S. Watkins, J. Stanson, J. T. Johnson, and T. L. Whiteside (1998)
J. Histochem. Cytochem. 46, 603-612
 |  Abstract »  |  Full Text »

Abnormal Myelocytic Cell Development in Interleukin-2 (IL-2)-Deficient Mice: Evidence for the Involvement of IL-2 in Myelopoiesis.

T. Reya, N. V. Contractor, M. S. Couzens, M. A. Wasik, S. G. Emerson, and S. R. Carding (1998)
Blood 91, 2935-2947
 |  Abstract »  |  Full Text »  |  PDF »

Regulation of Cell Growth by IL-2: Role of STAT5 in Protection from Apoptosis But Not in Cell Cycle Progression.

J. Zamorano, H. Y. Wang, R. Wang, Y. Shi, G. D. Longmore, and A. D. Keegan (1998)
J. Immunol. 160, 3502-3512
 |  Abstract »  |  Full Text »  |  PDF »

Further Analysis of Interleukin-2 Receptor Subunit Expression on the Different Human Peripheral Blood Mononuclear Cell Subsets.

D. David, L. Bani, J.-L. Moreau, C. Demaison, K. Sun, O. Salvucci, T. Nakarai, M. de Montalembert, S. Chouaib, M. Joussemet, et al. (1998)
Blood 91, 165-172
 |  Abstract »  |  Full Text »  |  PDF »

Tumor Immunology.

S. Shu, G. E. Plautz, J. C. Krauss, and A. E. Chang (1997)
JAMA 278, 1972-1981
 |  Abstract »  |  PDF »

The Role of Interleukin-2 in Combination Adenovirus Gene Therapy for Head and Neck Cancer.

B. W. O’Malley Jr., D. A. Sewell, D. Li, K.-i. Kosai, S.-H. Chen, S. L.C. Woo, and L. Duan (1997)
Mol. Endocrinol. 11, 667-673
 |  Abstract »  |  Full Text »

Topical Review: Gene Therapy for Neurologic Disease: Benchtop Discoveries to Bedside Applications. 1. The Bench.

B. L. Maria, C. D. Medina, K. B.N. Hoang, and M. I. Phillips (1997)
J Child Neurol 12, 1-12
 |  Abstract »  |  PDF »

Identification and Characterization of Two Alternative Splice Variants of Human Interleukin-2.

V. N. Tsytsikov, V. V. Yurovsky, S. P. Atamas, W. J. Alms, and B. White (1996)
J. Biol. Chem. 271, 23055-23060
 |  Abstract »  |  Full Text »  |  PDF »

Treatment of 283 Consecutive Patients With Metastatic Melanoma or Renal Cell Cancer Using High-Dose Bolus Interleukin 2.

S. A. Rosenberg, J. C. Yang, S. L. Topalian, D. J. Schwartzentruber, J. S. Weber, D. R. Parkinson, C. A. Seipp, J. H. Einhorn, and D. E. White (1994)
JAMA 271, 907-913
 |  Abstract »  |  PDF »

Immune responses in interleukin-2-deficient mice.

T. Kundig, H Schorle, M. Bachmann, H Hengartner, R. Zinkernagel, and I Horak (1993)
Science 262, 1059-1061
 |  Abstract »  |  PDF »

Adoptive Cellular Therapy of Malignancy.

A. E. Chang, J. D. Geiger, V. K Sondak, and S. Shu (1993)
Arch Surg 128, 1281-1290
 |  Abstract »  |  PDF »

Testing Hypotheses Derived from the Roy Adaptation Model.

K. Frederickson, B. S. Jackson, T. Strauman, and J. Strauman (1991)
Nurs Sci Q 4, 168-174
 |  Abstract »  |  PDF »

Randomized Study of Interleukin 2 (IL-2) Alone vs IL-2 Plus Lymphokine-Activated Killer Cells for Treatment of Melanoma and Renal Cell Cancer.

M. J. Koretz, D. H. Lawson, R. M. York, S. D. Graham, D. R. Murray, T. M. Gillespie, D. Levitt, and K. M. Sell (1991)
Arch Surg 126, 898-903
 |  Abstract »  |  PDF »

The Soluble Interleukin-2 Receptor: Biology, Function, and Clinical Application.

L. A. Rubin and D. L. Nelson (1990)
Ann Intern Med 113, 619-627
 |  Abstract »  |  PDF »

The untold story of HUT78.

E Rubinstein (1990)
Science 248, 1499-1507
 |  PDF »

Interleukin-2 receptor beta chain gene: generation of three receptor forms by cloned human alpha and beta chain cDNA's.

M Hatakeyama, M Tsudo, S Minamoto, T Kono, T Doi, T Miyata, M Miyasaka, and T Taniguchi (1989)
Science 244, 551-556
 |  Abstract »  |  PDF »

Ibuprofen Causes Reduced Toxic Effects of Interleukin 2 Administration in Patients With Metastatic Cancer.

T. J. Eberlein, D. D. Schoof, H. R. Michie, A. F. Massaro, U. Burger, D. W. Wilmore, and R. E. Wilson (1989)
Arch Surg 124, 542-547
 |  Abstract »  |  PDF »

Interleukin-2 in Scleroderma: Correlation of Serum Level with Extent of Skin Involvement and Disease Duration.

M. B. Kahaleh and C. E. LeRoy (1989)
Ann Intern Med 110, 446-450
 |  Abstract »  |  PDF »

The Hemodynamic Effects of Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells.

E. R. Gaynor, L. Vitek, L. Sticklin, S. P. Creekmore, M. E. Ferraro, J. X. Thomas Jr., S. G. Fisher, and R. I. Fisher (1988)
Ann Intern Med 109, 953-958
 |  Abstract »  |  PDF »

A New Regimen of Interleukin 2 and Lymphokine-Activated Killer Cells: Efficacy Without Significant Toxicity.

T. J. Eberlein, D. D. Schoof, S.-E. Jung, D. Davidson, B. Gramolini, K. McGrath, A. Massaro, and R. E. Wilson (1988)
Arch Intern Med 148, 2571-2576
 |  Abstract »  |  PDF »

Effect of Interleukin 2 on Kupffer Cell Activation: Interleukin 2 Primes and Activates Kupffer Cells to Suppress Hepatocyte Protein Synthesis In Vitro.

R. D. Curran, T. R. Billiar, M. A. West, B. G. Bentz, and R. L. Simmons (1988)
Arch Surg 123, 1373-1378
 |  Abstract »  |  PDF »

Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells.

S Nakamura, S. Salahuddin, P Biberfeld, B Ensoli, P. Markham, F Wong-Staal, and R. Gallo (1988)
Science 242, 426-430
 |  Abstract »  |  PDF »

New Approaches to the Immunotherapy of Cancer Using Interleukin-2.

S. A. ROSENBERG, M. T. LOTZE, and J. J. MULE (1988)
Ann Intern Med 108, 853-864
 |  Abstract »  |  PDF »

Interleukin-2: inception, impact, and implications.

K. Smith (1988)
Science 240, 1169-1176
 |  Abstract »  |  PDF »

Metastatic Renal Cancer Treated with Interleukin-2 and Lymphokine-Activated Killer Cells: A Phase II Clinical Trial.

R. I. FISHER, C. A. COLTMAN Jr., J. H. DOROSHOW, A. A. RAYNER, M. J. HAWKINS, J. W. MIER, P. WIERNIK, J. D. MCMANNIS, G. R. WEISS, K. A. MARGOLIN, et al. (1988)
Ann Intern Med 108, 518-523
 |  Abstract »  |  PDF »

Natural Killer Activity of Lymphocytes Infiltrating Human Lung Cancers Following Preoperative Systemic Recombinant Interleukin 2.

T. M. Anderson, Y. Ibayashi, Y. Tokuda, S. Colquhoun, C. Holmes, and S. H. Golub (1987)
Arch Surg 122, 1446-1450
 |  Abstract »  |  PDF »

Dermatologic Changes Associated With Interleukin 2 Administration.

A. A. Gaspari, M. T. Lotze, S. A. Rosenberg, J. B. Stern, and S. I. Katz (1987)
JAMA 258, 1624-1629
 |  Abstract »  |  PDF »

Effects of Interleukin-2 on Renal Function in Patients Receiving Immunotherapy for Advanced Cancer.

A. BELLDEGRUN, D. E. WEBB, H. A. AUSTIN III, S. M. STEINBERG, D. E. WHITE, W. M. LINEHAN, and S. A. ROSENBERG (1987)
Ann Intern Med 106, 817-822
 |  Abstract »  |  PDF »

Immune Interventions in Disease.

J. L. FAHEY, G. SARNA, R. P. GALE, and R. SEEGER (1987)
Ann Intern Med 106, 257-274
 |  Abstract »  |  PDF »

High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer: Responses, Treatment-Related Morbidity, and Histologic Findings.

M. T. Lotze, A. E. Chang, C. A. Seipp, C. Simpson, J. T. Vetto, and S. A. Rosenberg (1986)
JAMA 256, 3117-3124
 |  Abstract »  |  PDF »

Intraperitoneal Administration of Interleukin-2 in Patients With Cancer.

M. T. Lotze, M. C. Custer, and S. A. Rosenberg (1986)
Arch Surg 121, 1373-1379
 |  Abstract »  |  PDF »

Virus Isolation From and Identification of HTLV-III/LAV-Producing Cells in Brain Tissue From a Patient With AIDS.

S. Gartner, P. Markovits, D. M. Markovitz, R. F. Betts, and M. Popovic (1986)
JAMA 256, 2365-2371
 |  Abstract »  |  PDF »

Suppression of Cellular Immunity by Head and Neck Irradiation: Precipitating Factors and Reparative Mechanisms in an Experimental Model.

W. C. Gray, B. J. Hasslinger, C. M. Suter, C. L. Blanchard, A. L. Goldstein, and P. B. Chretien (1986)
Arch Otolaryngol Head Neck Surg 112, 1185-1190
 |  Abstract »  |  PDF »

Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders.

S. Salahuddin, D. Ablashi, P. Markham, S. Josephs, S Sturzenegger, M Kaplan, G Halligan, P Biberfeld, F Wong-Staal, B Kramarsky, et al. (1986)
Science 234, 596-601
 |  Abstract »  |  PDF »

Structure-activity studies of interleukin-2.

F. Cohen, P. Kosen, I. Kuntz, L. Epstein, T. Ciardelli, and K. Smith (1986)
Science 234, 349-352
 |  Abstract »  |  PDF »

Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA.

M Stevenson, B Volsky, M Hedenskog, and D. Volsky (1986)
Science 233, 980-984
 |  Abstract »  |  PDF »

Regulation of expression of the interleukin-2 receptor on hematopoietic cells by interleukin-3.

M. Birchenall-Sparks, W. Farrar, D Rennick, P. Kilian, and F. Ruscetti (1986)
Science 233, 455-458
 |  Abstract »  |  PDF »

The role of mononuclear phagocytes in HTLV-III/LAV infection.

S Gartner, P Markovits, D. Markovitz, M. Kaplan, R. Gallo, and M Popovic (1986)
Science 233, 215-219
 |  Abstract »  |  PDF »

The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes.

T. Waldmann (1986)
Science 232, 727-732
 |  Abstract »  |  PDF »

Interleukin-2 and Its Receptor: Structure and Functional Expression of the Genes.

T. Taniguchi, T. Fujita, M. Hatakeyama, H. Mori, H. Matsui, T. Sato, J. Hamuro, S. Minamoto, G. Yamada, and H. Shibuya (1986)
Cold Spring Harb Symp Quant Biol 51, 577-586
 |  Abstract »  |  PDF »

Structure of the human interleukin-2 receptor gene.

W. Leonard, J. Depper, M Kanehisa, M Kronke, N. Peffer, P. Svetlik, M Sullivan, and W. Greene (1985)
Science 230, 633-639
 |  Abstract »  |  PDF »

A Human T-Lymphotropic Retrovirus (HTLV-III) as the Cause of the Acquired Immunodeficiency Syndrome.

R. C. GALLO and F. WONG-STAAL (1985)
Ann Intern Med 103, 679-689
 |  Abstract »  |  PDF »

Localization of the gene encoding the human interleukin-2 receptor on chromosome 10.

W. Leonard, T. Donlon, R. Lebo, and W. Greene (1985)
Science 228, 1547-1549
 |  Abstract »  |  PDF »

Deregulation of interleukin-2 receptor gene expression in HTLV-I-induced adult T-cell leukemia.

M Kronke, W. Leonard, J. Depper, and W. Greene (1985)
Science 228, 1215-1217
 |  Abstract »  |  PDF »

Interleukin-1 stimulation of astroglial proliferation after brain injury.

D Giulian and L. Lachman (1985)
Science 228, 497-499
 |  Abstract »  |  PDF »

Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms.

C. Croce, M Isobe, A Palumbo, J Puck, J Ming, D Tweardy, J Erikson, M Davis, and G Rovera (1985)
Science 227, 1044-1047
 |  Abstract »  |  PDF »

Alteration of T-cell functions by infection with HTLV-I or HTLV-II.

M Popovic, N Flomenberg, D. Volkman, D Mann, A. Fauci, B Dupont, and R. Gallo (1984)
Science 226, 459-462
 |  Abstract »  |  PDF »

Site-specific mutagenesis of the human interleukin-2 gene: structure-function analysis of the cysteine residues.

A Wang, S. Lu, and D. Mark (1984)
Science 224, 1431-1433
 |  Abstract »  |  PDF »

The interleukin-2 T-cell system: a new cell growth model.

D. Cantrell and K. Smith (1984)
Science 224, 1312-1316
 |  Abstract »  |  PDF »

Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

M Popovic, M. Sarngadharan, E Read, and R. Gallo (1984)
Science 224, 497-500
 |  Abstract »  |  PDF »

T-Cell Lymphoproliferative Syndrome Associated with Human T-Cell Leukemia/Lymphoma Virus.

S. BRODER, P. A. BUNN Jr., E. S. JAFFE, W. BLATTNER, R. C. GALLO, F. WONG-STAAL, T. A. WALDMANN, and V. T. DeVITA Jr. (1984)
Ann Intern Med 100, 543-557
 |  Abstract »  |  PDF »

Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

S. Rosenberg, E. Grimm, M McGrogan, M Doyle, E Kawasaki, K Koths, and D. Mark (1984)
Science 223, 1412-1414
 |  Abstract »  |  PDF »

T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

S. Arya, F Wong-Staal, and R. Gallo (1984)
Science 223, 1086-1087
 |  Abstract »  |  PDF »

Lymphokine production by cultured human T cells transformed by human T-cell leukemia-lymphoma virus-I.

S. Salahuddin, P. Markham, S. Lindner, J Gootenberg, M Popovic, H Hemmi, P. Sarin, and R. Gallo (1984)
Science 223, 703-707
 |  Abstract »  |  PDF »

Gene for T-cell growth factor: location on human chromosome 4q and feline chromosome B1.

L. Seigel, M. Harper, F Wong-Staal, R. Gallo, W. Nash, and S. O'Brien (1984)
Science 223, 175-178
 |  Abstract »  |  PDF »

Human T-Cell Leukemia-Lymphoma Virus and Adult T-Cell Leukemia.

W. A. Blattner, K. Takatsuki, and R. C. Gallo (1983)
JAMA 250, 1074-1080
 |  Abstract »  |  PDF »

Isolation and transmission of human retrovirus (human t-cell leukemia virus).

M Popovic, P. Sarin, M Robert-Gurroff, V. Kalyanaraman, D Mann, J Minowada, and R. Gallo (1983)
Science 219, 856-859
 |  Abstract »  |  PDF »

Continuous lines of basophil/mast cells derived from normal mouse bone marrow.

K Nagao, K Yokoro, and S. Aaronson (1981)
Science 212, 333-335
 |  Abstract »  |  PDF »

To Advertise   |   Find Products